| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.06 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.32 | 0.07 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.31 | 0.07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |